Thymulin vs VIP (Vasoactive Intestinal Peptide)
A detailed comparison to help you understand the differences and choose the right peptide for your research goals.
Thymulin
Thymulin (Facteur Thymique Sérique) is a zinc-dependent nonapeptide hormone produced by thymic epithelial cells. It plays important roles in T-cell differentiation and immune system maturation.
Full details →VIP (Vasoactive Intestinal Peptide)
VIP is a 28-amino acid neuropeptide with wide-ranging effects throughout the body. It acts as a neurotransmitter, neuromodulator, and immune regulator with particular importance in gut and lung function.
Full details →Side-by-Side Comparison
| Aspect | Thymulin | VIP (Vasoactive Intestinal Peptide) |
|---|---|---|
| Dose Range | 100 mcg–400 mcg | 100 mcg–200 mcg |
| Frequency | 1x daily | 1x daily |
| Cycle Length | 4–8 weeks | 2–8 weeks |
| Route | subcutaneous | intranasal |
| Mechanism | Requires zinc for biological activity. Promotes T-cell differentiation, modulates cytokine production, and influences neuroendocrine function. Levels decline significantly with age. | Binds to VPAC1 and VPAC2 receptors to modulate immune responses, regulate circadian rhythms, promote vasodilation, and support barrier function in gut and lungs. Has potent anti-inflammatory effects. |
| Typical Dosage | Research protocols vary. Often studied alongside zinc supplementation. Typical research doses in the microgram range. | Intranasal: 50-200mcg 1-3 times daily for chronic inflammatory conditions. Some protocols use subcutaneous administration. Dosing varies by condition. |
| Administration | Subcutaneous or intramuscular injection in research settings. Requires adequate zinc status for activity. | Intranasal is most common for inflammatory conditions. Subcutaneous injection also used. Must be stored cold and protected from light. |
| Side Effects | Limited data on exogenous administration. Theoretical effects on immune function require monitoring. | May cause nasal irritation, flushing, headache, or temporary diarrhea. Generally well-tolerated at standard doses. |
| Best For |
What They Have in Common
Thymulin, VIP (Vasoactive Intestinal Peptide) are both commonly used for:
Key Differences
Unique to Thymulin:
Unique to VIP (Vasoactive Intestinal Peptide):
Which Has Stronger Evidence?
| Goal | Thymulin | VIP (Vasoactive Intestinal Peptide) |
|---|---|---|
| Immune Support | medium | medium |
Key Studies
Thymulin
- Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy.
Nature communications, 2026
- Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice.
International journal of immunopathology and pharmacology, 2021
- Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma.
Science advances, 2020
VIP (Vasoactive Intestinal Peptide)
- Distribution of vasoactive intestinal peptide (VIP) immunoreactivity in the rat pallial and subpallial amygdala and colocalization with γ-aminobutyric acid (GABA).
Anatomical record (Hoboken, N.J. : 2007), 2024
- Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF.
Frontiers in endocrinology, 2024
- Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis.
Frontiers in pharmacology, 2021
Ready to Learn More?
Looking for trusted sources?